MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $389,000 | -73.3% | 25,000 | -61.5% | 0.11% | -74.2% |
| Q3 2021 | $1,459,000 | -24.6% | 65,000 | -23.5% | 0.42% | -21.4% |
| Q2 2021 | $1,935,000 | +44.6% | 85,000 | +30.8% | 0.53% | +39.5% |
| Q1 2021 | $1,338,000 | -3.1% | 65,000 | +30.0% | 0.38% | -7.1% |
| Q4 2020 | $1,381,000 | +96.4% | 50,000 | 0.0% | 0.41% | +91.2% |
| Q3 2020 | $703,000 | – | 50,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |